Abstract:BackgroundToday, the treatment of choice for high- and low-grade gliomas requires primarily surgical resection to achieve the best survival and quality of life. Nevertheless, many gliomas within highly eloquent cortical regions, e.g., insula, rolandic, and left perisylvian cortex, still do not undergo surgery because of the impending risk of surgery-related deficits at some centers. However, pre and intraoperative brain mapping, intraoperative neuromonitoring (IOM), and awake surgery increase safety, which all… Show more
“…30 However, both T1-CE and FET-PET were of equal value for the prediction of postoperative functional outcome: While the absence of overlap with functional tissue maps predicted a favorable outcome, the presence of overlap before the operation was associated with a considerably higher risk of motor deterioration after the operation (33%) compared with the risk of the entire sample (14%) or with the risk reported in the literature, ranging from 6% to 19%. [3][4][5] These findings need to be confirmed in a larger series but may be of great value in more wisely selecting and advising patients with brain tumors in the proximity of the CST or M1 for operative tumor removal. Not surprising, the sensitivity of either FET-PET or T1-CE in revealing motor deficits before the operation was limited.…”
Section: Discussionmentioning
confidence: 95%
“…2 A frequently encountered phenomenon in patients presenting with tumors in the vicinity of motor regions is that some of them have motor impairment while others do not, and some deteriorate after the operation while others may even improve. [3][4][5] In some patients, motor deficits can be explained by direct infiltration of the tumor into the motor cortex or corticospinal tract (CST), while in other patients, compression effects resulting from the tumor mass and/or perifocal edema may cause motor symptoms. 5 Differentiating causes is, however, highly relevant with respect to the reversibility of symptoms and planning of operations.…”
BACKGROUND AND PURPOSE:Motor deficits in patients with brain tumors are caused mainly by irreversible infiltration of the motor network or by indirect mass effects; these deficits are potentially reversible on tumor removal. Here we used a novel multimodal imaging approach consisting of structural, functional, and metabolic neuroimaging to better distinguish these underlying causes in a preoperative setting and determine the predictive value of this approach.
“…30 However, both T1-CE and FET-PET were of equal value for the prediction of postoperative functional outcome: While the absence of overlap with functional tissue maps predicted a favorable outcome, the presence of overlap before the operation was associated with a considerably higher risk of motor deterioration after the operation (33%) compared with the risk of the entire sample (14%) or with the risk reported in the literature, ranging from 6% to 19%. [3][4][5] These findings need to be confirmed in a larger series but may be of great value in more wisely selecting and advising patients with brain tumors in the proximity of the CST or M1 for operative tumor removal. Not surprising, the sensitivity of either FET-PET or T1-CE in revealing motor deficits before the operation was limited.…”
Section: Discussionmentioning
confidence: 95%
“…2 A frequently encountered phenomenon in patients presenting with tumors in the vicinity of motor regions is that some of them have motor impairment while others do not, and some deteriorate after the operation while others may even improve. [3][4][5] In some patients, motor deficits can be explained by direct infiltration of the tumor into the motor cortex or corticospinal tract (CST), while in other patients, compression effects resulting from the tumor mass and/or perifocal edema may cause motor symptoms. 5 Differentiating causes is, however, highly relevant with respect to the reversibility of symptoms and planning of operations.…”
BACKGROUND AND PURPOSE:Motor deficits in patients with brain tumors are caused mainly by irreversible infiltration of the motor network or by indirect mass effects; these deficits are potentially reversible on tumor removal. Here we used a novel multimodal imaging approach consisting of structural, functional, and metabolic neuroimaging to better distinguish these underlying causes in a preoperative setting and determine the predictive value of this approach.
“…There were 19 studies identified using craniotomy [3,4,7,9,10,11,12,32,33,34,35,36,37,38,39,40,41,42,43]. Of these, 6 articles were excluded [3,32,37,42,43] due to an inability to break out complications related to surgery in areas of eloquence.…”
Section: Resultsmentioning
confidence: 99%
“…It was found that 3 such complications occurred in these studies (table 2). There were 11 craniotomy studies totaling 1,036 patients included in this analysis [3,9,10,11,12,34,35,36,39,40,41]. There were 141 such complications that occurred (table 2).…”
Background: The extent of resection (EOR) of high-grade gliomas (WHO grade III or IV) in or near areas of eloquence is associated with overall patient survival, but with higher major neurocognitive complications. Methods: A systematic review and meta-analysis was undertaken of the peer-reviewed literature in order to identify studies which examined EOR or extent of ablation (EOA) and major complications (defined as neurocognitive or functional complications which last >3 months duration after surgery) associated with either brain laser interstitial thermal therapy (LITT) or open craniotomy in high-grade tumors in or near areas of eloquence. Results: Eight studies on brain LITT (n = 79 patients) and 12 craniotomy studies (n = 1,036 patients) were identified which examined either/both EOR/EOA and complications. Meta-analysis demonstrated an EOA/EOR of 85.4 ± 10.6% with brain LITT versus 77.0 ± 40% with craniotomy (mean difference: 8%; 95% CI: 2-15; p = 0.01; inverse variance, random effects model). Meta-analysis of proportions of major complications for each individual therapy demonstrated major complications of 5.7% (95% CI: 1.8-11.6) and 13.8% (95% CI: 10.3-17.9) for LITT and craniotomy, respectively. Conclusion: In patients presenting with high-grade gliomas in or near areas of eloquence, early results demonstrate that brain LITT may be a viable surgical alternative.
“…The correct surgical planning for radical resection of gliomas allows a better quality of life and increases patient survival 13,[24][25][26][27][28] . However, there is a potentially high risk of permanent sequelae, particularly when the tumor is located within eloquent brain regions.…”
Section: Evolution Of Neurological Deficitmentioning
Introduction: Resection of gliomas in eloquent areas such as motor and supplementary motor areas has always been a main challenge for the surgeon due to the risk of severe neurological sequelae. An important tool used during the procedure to avoid postoperative deficits is the intraoperative cortical stimulation of eloquent areas as a safe option of functional area mapping. Methods: In this study, authors examined 50 patients with gliomas located in the motor and supplementary motor area that have undergone surgery with cortical stimulation, using clinical assessment of muscle strength in the pre-and immediate postoperative assessments and three months after surgery as parameters. Results: There was significant difference (p<0.001) between the preoperative and immediate postoperative assessments regarding the occurrence of severe neurological deficit, demonstrating a worsening of the neurological status after surgery. Concerning the comparison between the immediate postoperative period and the assessment performed three months after surgery, it was observed that all the patients who had severe deficit (11 cases) improved (p<0.001). No statistical difference was found between the malignancy grade and the evolution of the neurological deficit in the assessments performed in the three evaluated periods. Conclusion: In the immediate postoperative period following surgical resection of glial tumors in the motor and supplementary motor areas with intraoperative cortical monitoring, most patients have significant alterations in their muscle strength. However, three months after surgery there was significant improvement of these neurological deficits and no patient had severe sequelae.
RESUMOIntrodução: A ressecção de gliomas em áreas eloquentes como as áreas motora e a motora suplementar sempre foi um dos principais desafios para o cirurgião, devido ao risco de sequelas neurológicas graves. Durante o procedimento, uma importante ferramenta utilizada para evitar déficits pós-operatórios é a estimulação cortical intraoperatória de áreas eloquentes como uma opção segura de mapeamento de área funcional. Métodos: Neste estudo, os autores examinaram 50 pacientes, com gliomas localizados nas áreas motora e motora suplementar que foram submetidos a cirurgia sob estimulação cortical, através de avaliação clínica de força muscular nos períodos pré-operatório e pós-operatório imediato e três meses após a cirurgia como parâmetro. Resultados: Houve diferença significativa (p < 0,001) entre as avaliações pré-operatória e pós-operatória imediata com relação à ocorrência de déficit neurológico severo, demonstrando uma piora da condição neurológica após a cirurgia. Sobre a comparação entre o período pós-operatório imediato e a avaliação realizada três meses após a cirurgia, observamos que todos os pacientes que apresentavam déficit severo (11 casos) melhoraram (p < 0,001). Nenhuma diferença estatística foi encontrada entre o grau de malignidade e a evolução do déficit neurológico nos levantamentos realizados nos três períodos avaliados....
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.